05/01/2026
Informative article by Healio featuring Dr. Julie Silverstein, emphasizing new data on once-weekly therapy for adults with growth hormone deficiency and its impact on long-term outcomes:
LAS VEGAS — A once-weekly therapy to treat growth hormone deficiency was well tolerated and conferred improvements in multiple body composition measures at 1 year, according to long-term extension trial data. In July 2025, Ascendis Pharma announced that, based on data from the phase 3 foresiGHt tr...